fbpx

Esophagıtıs

Updated : September 16, 2022





Background

Epidemiology

Anatomy

Pathophysiology

Etiology

Genetics

Prognostic Factors

Clinical History

Physical Examination

Age group

Associated comorbidity

Associated activity

Acuity of presentation

Differential Diagnoses

Laboratory Studies

Imaging Studies

Procedures

Histologic Findings

Staging

Treatment Paradigm

by Stage

by Modality

Chemotherapy

Radiation Therapy

Surgical Interventions

Hormone Therapy

Immunotherapy

Hyperthermia

Photodynamic Therapy

Stem Cell Transplant

Targeted Therapy

Palliative Care

Medication

 

vonoprazan fumarate 

Indicated for reflux esophagitis
The oral dosage is 20 mg to be taken one time daily, following a treatment duration of 4 weeks
In cases where this dosage is found to be inadequate, the administration can be extended; but it should not exceed a total treatment period of 8 weeks
For reflux esophagitis maintenance therapy, an oral dosage of 10 mg should be taken one time daily
In cases where the desired outcome is not achieved, the dosage may be maximized to 20 mg one time daily



 
 

Media Gallary

References

Esophagıtıs

Updated : September 16, 2022




vonoprazan fumarate 

Indicated for reflux esophagitis
The oral dosage is 20 mg to be taken one time daily, following a treatment duration of 4 weeks
In cases where this dosage is found to be inadequate, the administration can be extended; but it should not exceed a total treatment period of 8 weeks
For reflux esophagitis maintenance therapy, an oral dosage of 10 mg should be taken one time daily
In cases where the desired outcome is not achieved, the dosage may be maximized to 20 mg one time daily